\-\ Texto\\:\\ \ \(0\)\
\-\ sp02\\ in\\ mid\\ 90\\'s\\ initially\\ and\\ after\\ a\\ few\\ hours\\ dipped\\ into\\ the\\ mid\\ 80\\'s\\.\ \(0\)\
\-\ wbc\\ 18\ \(0\)\
\-\ temp\\ 101f\ \(0\)\
\-\ antibiotics\\.\ \(66\)\
\-\ o2\ \(2\)\
\-\ fluids\ \(25\)\
\-\ pain\\ control\\.\ \(9\)\
\-\ cxr\\:\\ patchy\\,\\ bibasilar\\ predominant\\ opacities\\ obscuring\\ hemidiaphragms\\.\\ sclerosis\\ of\\ bilateral\\ humeral\\ heads\\.\\ splenectomy\\.\ \(0\)\
\-\ acute\\ chest\\ syndrome\ \(8\)\
\-\ pneumonia\\ \\-\\ bacterial\\,\\ atypical\ \(0\)\
\-\ pulmonary\\ edema\ \(53\)\
\-\ pulmonary\\ hemorrhage\ \(11\)\
\-\ 22yo\\ aa\\ male\\ with\\ known\\ sickle\\ cell\\ disease\\ presents\\ with\\ fever\\,\\ cough\\ for\\ the\\ last\\ two\\ days\\.\ \(0\)\
\-\ although\\ in\\ this\\ case\\ the\\ etiology\\ of\\ the\\ event\\ was\\ infection\\,\\ a\\ similar\\ chest\\ radiograph\\ could\\ be\\ secondary\\ to\\ many\\ different\\ causes\\.\\ \\ even\\ if\\ previous\\ knowledge\\ of\\ sickle\\ cell\\ disease\\ was\\ not\\ known\\,\\ it\\ can\\ be\\ suspected\\ with\\ the\\ additional\\ findings\\ of\\ humeral\\ head\\ infarcts\\ and\\ splenectomy\\.\ \(0\)\
\-\ acute\\ chest\\ syndrome\\ in\\ sickle\\ cell\\ disease\\ can\\ be\\ defined\\ as\\:\\ a\\ new\\ infiltrate\\ on\\ chest\\ x\\-ray\\ in\\ association\\ with\\ one\\ or\\ more\\ new\\ symptoms\\:\\ fever\\,\\ cough\\,\\ sputum\\ production\\,\\ dyspnea\\,\\ or\\ hypoxia\\.\\ this\\ is\\ a\\ common\\ complication\\ of\\ the\\ sickling\\ blood\\ dyscrasias\\,\\ including\\ hb\\ ss\\,\\ hb\\ sc\\,\\ hb\\ s\\ \\?\\+\\-thalassemia\\,\\ hb\\ s\\ \\?0\\-thalassemia\\,\\ etc\\.\\ \\ this\\ complication\\ occurs\\ with\\ an\\ incidence\\ of\\ 10\\,500\\/100\\,000\\ patients\\ per\\ year\\.\ \(0\)\
\-\ acute\\ chest\\ syndrome\\ occurs\\ typically\\ only\\ once\\ in\\ a\\ patient\\'s\\ life\\,\\ more\\ common\\ in\\ the\\ younger\\ population\\,\\ usually\\ 3\\-5yrs\\ of\\ age\\.\\ \\ however\\,\\ if\\ more\\ than\\ one\\ event\\ occurs\\,\\ significant\\ mortality\\ and\\ morbity\\ is\\ associated\\ with\\ it\\.\ \(0\)\
\-\ the\\ role\\ of\\ radiology\\ is\\ to\\ track\\ the\\ evolution\\ of\\ chest\\ findings\\.\\ \\ complications\\ of\\ acute\\ chest\\ syndrome\\ include\\:\\ pulmonary\\ infarction\\,\\ fat\\ embolism\\ syndrome\\,\\ hypoventilation\\ secondary\\ to\\ rib\\/sternal\\ bone\\ infarction\\,\\ hypoventilation\\ secondary\\ to\\ narcotic\\ administration\\,\\ and\\ pulmonary\\ edema\\ induced\\ by\\ narcotics\\ or\\ fluid\\ overload\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hb\\:\\ 0\\.32648282505567033\ \(0\)\
\-\ chest\\:\\ 0\\.23192268701740165\ \(0\)\
\-\ hypoventilation\\:\\ 0\\.19183447287105795\ \(0\)\
\-\ syndrome\\:\\ 0\\.18920015235741497\ \(0\)\
\-\ sickle\\:\\ 0\\.18621976355504097\ \(0\)\
\-\ splenectomy\\:\\ 0\\.15641589515474646\ \(0\)\
\-\ pulmonary\\:\\ 0\\.1530384867342055\ \(0\)\
\-\ occurs\\:\\ 0\\.1484649181612892\ \(0\)\
\-\ acute\\:\\ 0\\.13581904660583538\ \(0\)\
\-\ event\\:\\ 0\\.12518639380731417\ \(0\)\
\-\ of\\:\\ 0\\.12283301628444047\ \(0\)\
\-\ humeral\\:\\ 0\\.120997317438435\ \(0\)\
\-\ complication\\:\\ 0\\.11401586106269784\ \(0\)\
\-\ the\\:\\ 0\\.11271932920653183\ \(0\)\
\-\ secondary\\:\\ 0\\.11161145584432705\ \(0\)\
\-\ cell\\:\\ 0\\.10771752754503822\ \(0\)\
\-\ more\\:\\ 0\\.10339804197094497\ \(0\)\
\-\ sp02\\:\\ 0\\.10037873113868971\ \(0\)\
\-\ dipped\\:\\ 0\\.10037873113868971\ \(0\)\
\-\ infarction\\:\\ 0\\.09854928218214144\ \(0\)\
\-\ 101f\\:\\ 0\\.09591723643552898\ \(0\)\
\-\ sickling\\:\\ 0\\.09591723643552898\ \(0\)\
\-\ morbity\\:\\ 0\\.09591723643552898\ \(0\)\
\-\ cough\\:\\ 0\\.09372341147920402\ \(0\)\
\-\ in\\:\\ 0\\.09368694679116725\ \(0\)\
\-\ dyscrasias\\:\\ 0\\.09275175556733171\ \(0\)\
\-\ mid\\:\\ 0\\.09034319003251073\ \(0\)\
\-\ narcotic\\:\\ 0\\.08829026086417097\ \(0\)\
\-\ new\\:\\ 0\\.08684697206333854\ \(0\)\
\-\ 22yo\\:\\ 0\\.08659407929938273\ \(0\)\
\-\ fever\\:\\ 0\\.08511419899756603\ \(0\)\
\-\ hemidiaphragms\\:\\ 0\\.08266944228053398\ \(0\)\
\-\ narcotics\\:\\ 0\\.08266944228053398\ \(0\)\
\-\ sc\\:\\ 0\\.08162070626391758\ \(0\)\
\-\ known\\:\\ 0\\.08127494069504243\ \(0\)\
\-\ ss\\:\\ 0\\.07978254337650273\ \(0\)\
\-\ disease\\:\\ 0\\.07904256937635999\ \(0\)\
\-\ overload\\:\\ 0\\.07896710372802473\ \(0\)\
\-\ obscuring\\:\\ 0\\.07820794757737323\ \(0\)\
\-\ knowledge\\:\\ 0\\.07820794757737323\ \(0\)\
\-\ be\\:\\ 0\\.07638667008929739\ \(0\)\
\-\ edema\\:\\ 0\\.07487170697360213\ \(0\)\
\-\ with\\:\\ 0\\.07374384538944057\ \(0\)\
\-\ evolution\\:\\ 0\\.07350461017567647\ \(0\)\
\-\ if\\:\\ 0\\.07293883405974302\ \(0\)\
\-\ fluids\\:\\ 0\\.07215556780514472\ \(0\)\
\-\ one\\:\\ 0\\.07187456164327745\ \(0\)\
\-\ common\\:\\ 0\\.07119260624136786\ \(0\)\
\-\ bibasilar\\:\\ 0\\.0709540043340883\ \(0\)\
\-\ aa\\:\\ 0\\.0709540043340883\ \(0\)\
\-\ predominant\\:\\ 0\\.07058097200601524\ \(0\)\
\-\ sputum\\:\\ 0\\.0702201724750151\ \(0\)\
\-\ track\\:\\ 0\\.06987082885325771\ \(0\)\
\-\ hypoxia\\:\\ 0\\.06920375189963981\ \(0\)\
\-\ heads\\:\\ 0\\.06769407310198397\ \(0\)\
\-\ production\\:\\ 0\\.06741549113781799\ \(0\)\
\-\ infiltrate\\:\\ 0\\.0666197179822139\ \(0\)\
\-\ role\\:\\ 0\\.06587763460431847\ \(0\)\
\-\ can\\:\\ 0\\.06587668215216716\ \(0\)\
\-\ younger\\:\\ 0\\.06564099322936488\ \(0\)\
\-\ or\\:\\ 0\\.0655069785071416\ \(0\)\
\-\ o2\\:\\ 0\\.06474225719647907\ \(0\)\
\-\ this\\:\\ 0\\.06470402312047027\ \(0\)\
\-\ it\\:\\ 0\\.06425950571970593\ \(0\)\
\-\ to\\:\\ 0\\.06276690309448114\ \(0\)\
\-\ temp\\:\\ 0\\.062243853281899714\ \(0\)\
\-\ induced\\:\\ 0\\.062243853281899714\ \(0\)\
\-\ findings\\:\\ 0\\.061956455346909314\ \(0\)\
\-\ etc\\:\\ 0\\.06173979264074746\ \(0\)\
\-\ mortality\\:\\ 0\\.06173979264074746\ \(0\)\
\-\ infarcts\\:\\ 0\\.061416139901157726\ \(0\)\
\-\ patchy\\:\\ 0\\.06110173565955628\ \(0\)\
\-\ opacities\\:\\ 0\\.0599269249365041\ \(0\)\
\-\ population\\:\\ 0\\.05938343670072072\ \(0\)\
\-\ once\\:\\ 0\\.058992742410855906\ \(0\)\
\-\ bacterial\\:\\ 0\\.058739779549843586\ \(0\)\
\-\ different\\:\\ 0\\.05744376571488009\ \(0\)\
\-\ embolism\\:\\ 0\\.05690161666242872\ \(0\)\
\-\ association\\:\\ 0\\.056486344743775486\ \(0\)\
\-\ dyspnea\\:\\ 0\\.05523570581778746\ \(0\)\
\-\ incidence\\:\\ 0\\.05403100702833575\ \(0\)\
\-\ control\\:\\ 0\\.05363083929851099\ \(0\)\
\-\ few\\:\\ 0\\.05324471547593256\ \(0\)\
\-\ even\\:\\ 0\\.05279857058761337\ \(0\)\
\-\ per\\:\\ 0\\.052092982765011474\ \(0\)\
\-\ and\\:\\ 0\\.05188045592364145\ \(0\)\
\-\ is\\:\\ 0\\.051567833732537\ \(0\)\
\-\ atypical\\:\\ 0\\.051494463041484084\ \(0\)\
\-\ life\\:\\ 0\\.051494463041484084\ \(0\)\
\-\ suspected\\:\\ 0\\.05142992678707647\ \(0\)\
\-\ last\\:\\ 0\\.05105046160302727\ \(0\)\
\-\ etiology\\:\\ 0\\.05056404429211127\ \(0\)\
\-\ radiology\\:\\ 0\\.05027060290660023\ \(0\)\
\-\ cxr\\:\\ 0\\.05021284214491518\ \(0\)\
\-\ 90\\:\\ 0\\.05015538300738097\ \(0\)\
\-\ administration\\:\\ 0\\.04998478424382824\ \(0\)\
\-\ pneumonia\\:\\ 0\\.049542376923423316\ \(0\)\
\-\ many\\:\\ 0\\.049488306053763066\ \(0\)\
\-\ initially\\:\\ 0\\.04922186688998382\ \(0\)\
\-\ 80\\:\\ 0\\.04896172711829174\ \(0\)\
\-\ additional\\:\\ 0\\.04865746626304585\ \(0\)\
\-\ complications\\:\\ 0\\.0480730776200143\ \(0\)\
\-\ hours\\:\\ 0\\.04783845466198535\ \(0\)\
\-\ similar\\:\\ 0\\.04783845466198535\ \(0\)\
\-\ 18\\:\\ 0\\.047563355337454\ \(0\)\
\-\ causes\\:\\ 0\\.04742834260266876\ \(0\)\
\-\ previous\\:\\ 0\\.04742834260266876\ \(0\)\
\-\ antibiotics\\:\\ 0\\.04624221383723444\ \(0\)\
\-\ could\\:\\ 0\\.04565574823194791\ \(0\)\
\-\ including\\:\\ 0\\.044919460256830177\ \(0\)\
\-\ defined\\:\\ 0\\.04477793547839522\ \(0\)\
\-\ sclerosis\\:\\ 0\\.0447078498921895\ \(0\)\
\-\ wbc\\:\\ 0\\.044363965660191254\ \(0\)\
\-\ typically\\:\\ 0\\.04406339887385891\ \(0\)\
\-\ was\\:\\ 0\\.04375011805334787\ \(0\)\
\-\ although\\:\\ 0\\.04273084100054331\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.042024346794870715\ \(0\)\
\-\ radiograph\\:\\ 0\\.04088145816738849\ \(0\)\
\-\ days\\:\\ 0\\.03973447685672436\ \(0\)\
\-\ usually\\:\\ 0\\.039514401524008716\ \(0\)\
\-\ age\\:\\ 0\\.03940599276696533\ \(0\)\
\-\ only\\:\\ 0\\.03921350856121505\ \(0\)\
\-\ fat\\:\\ 0\\.03904519323596518\ \(0\)\
\-\ infection\\:\\ 0\\.037915139294404016\ \(0\)\
\-\ head\\:\\ 0\\.03743585348680106\ \(0\)\
\-\ include\\:\\ 0\\.03734602931587103\ \(0\)\
\-\ two\\:\\ 0\\.03727469422107319\ \(0\)\
\-\ however\\:\\ 0\\.03715095990703722\ \(0\)\
\-\ blood\\:\\ 0\\.03645290779971705\ \(0\)\
\-\ significant\\:\\ 0\\.03624051189876808\ \(0\)\
\-\ fluid\\:\\ 0\\.03624051189876808\ \(0\)\
\-\ than\\:\\ 0\\.0355810523908222\ \(0\)\
\-\ patients\\:\\ 0\\.03531009314939527\ \(0\)\
\-\ symptoms\\:\\ 0\\.03434276366809045\ \(0\)\
\-\ bone\\:\\ 0\\.034247847739020794\ \(0\)\
\-\ bilateral\\:\\ 0\\.03373351493429181\ \(0\)\
\-\ into\\:\\ 0\\.03336606732525012\ \(0\)\
\-\ associated\\:\\ 0\\.03308312474173662\ \(0\)\
\-\ case\\:\\ 0\\.031533657348301145\ \(0\)\
\-\ after\\:\\ 0\\.030449492871903985\ \(0\)\
\-\ presents\\:\\ 0\\.030194357529723322\ \(0\)\
\-\ male\\:\\ 0\\.02794645937379218\ \(0\)\
\-\ by\\:\\ 0\\.026654676802035523\ \(0\)\
\-\ as\\:\\ 0\\.025215890720615586\ \(0\)\
\-\ not\\:\\ 0\\.024779074967862687\ \(0\)\
\-\ an\\:\\ 0\\.02400204164051876\ \(0\)\
\-\ pain\\:\\ 0\\.02246048430825106\ \(0\)\
\-\ patient\\:\\ 0\\.020415083012240702\ \(0\)\
\-\ year\\:\\ 0\\.0193436757461682\ \(0\)\
\-\ for\\:\\ 0\\.019024316089954384\ \(0\)\
\-\ on\\:\\ 0\\.01895683105882997\ \(0\)\
